When I carried a quota, the comparison I feared was the one where the buyer priced the whole stack, not the core. The core is a clean number designed to look competitive. The money is in discovery, automation, AIOps and the AI add-ons that get quoted later, once you are committed. Ivanti and BMC both play this game. So before you let either desk frame the contest, frame it yourself. This article sits under our 2026 ITSM platform cost comparison of 12 tools benchmarked, which is the place to start if you are still building the shortlist.
Which one is actually cheaper?
It depends entirely on what your estate is shaped like. Ivanti Neurons grew out of unified endpoint and asset management, so for an estate that is device-heavy, distributed and asset-led, its economics tend to land lower because you are buying into its strength. BMC Helix grew out of enterprise ITSM and operations, so for a large, process-heavy estate that needs deep ITOM, discovery and AIOps, it tends to price higher but covers more without third-party glue.
Neither publishes a rate card you can trust as a benchmark. Both discount off an internal list against committed spend and term, the same way every enterprise vendor does. So "cheaper" is not a property of the logo. It is a property of your module mix, your agent count and how hard you make each desk compete.
How do the two compare line by line?
Use this as the structure for your own comparison. The cost notes are directional, not quotes, because real numbers vary by deal size and must be confirmed against each order form.
| Dimension | Ivanti Neurons | BMC Helix |
|---|---|---|
| Core strength | Unified endpoint, asset and patch, with ITSM built around it | Enterprise ITSM, ITOM and AIOps depth |
| Licensing basis | Agent and node based, asset counts drive cost | Agent based, with module and consumption layers |
| AI add-on | Neurons automation and AI capabilities, priced as add-ons | BMC HelixGPT and AIOps, priced as add-ons or consumption |
| Where cost hides | Discovery, automation packs and asset module scope | ITOM, AIOps and HelixGPT consumption |
| Best fit | Asset-heavy, endpoint-led, distributed estates | Large, process-heavy enterprise operations |
| Deployment | Cloud and on-premise options | SaaS-led, with managed and on-premise paths |
What drives the real cost difference?
The add-on stack, every time. Both vendors quote a reasonable core, then the modules arrive: discovery, automation, asset management, AIOps, and the AI layer on top. Each is a separate negotiation, and each is where the desk recovers margin. Price them individually. A blended platform number lets the vendor hide which line is overpriced for what you actually use.
Watch the asset-count mechanics on Ivanti and the consumption mechanics on BMC. Ivanti cost scales with managed nodes and assets, so an inflated CMDB inflates your bill. BMC AIOps and HelixGPT can meter on consumption, so usage you do not cap becomes a variable you do not control. Both are fixable in contract, but only if you raise them before signing.
How do you use one to negotiate the other down?
This is the part vendors least want you to do, which is exactly why it works. Run a genuine, costed comparison and make sure both desks know the deal is contestable.
- Build a real alternative quote. Not a bluff. A scoped, costed comparison for the same agents and modules, so the number survives scrutiny.
- Normalize to net cost per agent. Strip the headlines and compare like for like, including the add-ons each side needs to match the other.
- Time the renewal against the incumbent's quarter-end. A contestable deal at quarter-end is where the discretionary discount lives.
- Hold the add-ons separate. Negotiate the AI and automation layer on its own short term so you can re-price it once you have usage data.
You do not need to intend to switch. You need both vendors to believe you could. Across our engagements the firm averages a 30% reduction, and a credible cross-vendor alternative is one of the most reliable ways we get there. The discipline is in our BMC Helix vs ServiceNow on AI and automation cost comparison, which runs the same play against a different rival.
Our gated ITSM Competitive Leverage Playbook sets out how to stage a credible alternative without committing to a switch.
Book a competitive leverage review.
We build the costed alternative and run both desks against each other to a defensible number. Fixed fee or gainshare, no savings no fee.
Book a competitive leverage review →What to do next
Decide which strength your estate actually needs before you let either vendor frame the contest. If you are asset-led, Ivanti is the cheaper centre of gravity and BMC is your leverage. If you need genuine enterprise ITOM and AIOps, BMC is the centre and Ivanti is your leverage. Either way, normalize to net cost per agent and price the add-ons separately. When you want the comparison built and run for you, the engagement goes through our competitive leverage service, and the platform hubs are the Ivanti platform page and the BMC Helix platform page.
Frequently asked questions
- Is Ivanti Neurons cheaper than BMC Helix?
- It depends on estate shape. Ivanti tends to price lower for asset-heavy, endpoint-led estates; BMC Helix prices higher but carries deeper enterprise ITSM, ITOM and AIOps. Compare net cost per agent for your module mix, not the logo.
- What is the biggest cost difference?
- The add-on stack. BMC loads cost into ITOM, AIOps and HelixGPT; Ivanti loads it into discovery, automation and asset scope. Price the add-ons line by line.
- How do I use one as leverage against the other?
- Run a genuine costed comparison and let each desk know the deal is contestable. You do not need to switch to benefit, only to make both believe you could.